Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Contributors in Cancer drugs

Cancer drugs

An orally-active synthetic phenylretinamide analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities. Fenretinide binds to and activates retinoic acid receptors ...

Amifampridine

Pharmaceutical; Cancer drugs

An organic compound derived from pyridine with potassium channel inhibition activity. Amifampridine inhibits potassium channel efflux, increasing the duration of the action potential, which results ...

Nitroglycerin

Pharmaceutical; Cancer drugs

An organic nitrate with vasodilator activity. Nitroglycerin is converted into nitric oxide (NO) in smooth muscle and activates guanylyl cyclase, thereby increasing cGMP concentration, and resulting ...

PNP-expressing ovine atadenovirus FP253

Pharmaceutical; Cancer drugs

An ovine atadenovirus encoding E. Coli purine nucleoside phosphorylase (PNP) with prodrug activating activity. Under the control of a prostate-directed promoter, PNP-expressing atadenovirus vaccine ...

Ad5.SSTR/TK.RGD

Pharmaceutical; Cancer drugs

An RGD-4C–modified, infectivity-enhanced, bicistronic type 5 adenovirus expressing herpes simplex virus thymidine kinase (HSV-tk) gene, a therapeutic suicide gene, and the somatostatin receptor type ...

Re-186 hydroxyethylidene diphosphonate

Pharmaceutical; Cancer drugs

An synthetic compound containing the organic phosphonate hydroxyethylidene diphosphonate (HEDP) labelled with the radioisotope rhenium Re 186. Re-186 hydroxyethylidene diphosphonate binds to ...

Semuloparin

Pharmaceutical; Cancer drugs

An ultralow-molecular-weight heparin (ULMWH) (Mw: 2000-3000 daltons) consisting of a polydisperse mixture of oligomeric heparin fragments with potential anticoagulant activity. Semuloparin binds to ...